SCHEMBL5380338

SCHEMBL5380338

Cc1ccc(S(=O)(=O)Nc2ccc(SCc3cc(F)cc(F)c3)cc2)cc1C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.56
CASP6 P55212 1/20 0.47
GFER P55789 1/20 0.47
PABPC1 P11940 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
MCL1 Q07820 1/20 0.44
BCL2A1 Q16548 1/20 0.44
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
LMNA P02545 1/20 0.42
MAPK1 P28482 2/20 0.42
MIF P14174 1/20 0.42
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 1/20 0.41
PKM P14618 1/20 0.41
KMT2A Q03164 1/20 0.41
METAP2 P50579 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5386741 0.92 POLB (0.56) POLBCASP6GFERPABPC1SMN1; SMN2
SCHEMBL5376596 0.90 POLB (0.49) POLBCASP6GFERPABPC1SMN1; SMN2
SCHEMBL5390814 0.89 POLB (0.58) POLBCASP6GFERPABPC1SMN1; SMN2
SCHEMBL5391181 0.88 POLB (0.54) POLBCASP6GFERPABPC1SMN1; SMN2
Cp-778875 SCHEMBL1600965 0.87 POLB (0.58) POLBCASP6GFERPABPC1SMN1; SMN2
SCHEMBL5375209 0.87 POLB (0.58) POLBCASP6GFERPABPC1SMN1; SMN2
SCHEMBL5373144 0.87 POLB (0.53) POLBCASP6GFERPABPC1SMN1; SMN2
SCHEMBL5388054 0.85 POLB (0.56) POLBCASP6GFERPABPC1SMN1; SMN2
SCHEMBL14437715 0.85 POLB (0.56) POLBCASP6GFERPABPC1SMN1; SMN2
SCHEMBL5371856 0.85 POLB (0.53) POLBCASP6GFERPABPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD POLB 1807/4885CASP6 3606/4885GFER 3619/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD POLB 2006/4885CASP6 3811/4885GFER 2976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.